Trial Profile
Double-Blind Randomized Evaluation of Clinical Benefits of DOXIL in Patients With AIDS-Related Kaposi's Sarcoma Treated With DOXIL or DaunoXome
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Feb 2013
Price :
$35
*
At a glance
- Drugs Daunorubicin (Primary) ; Doxorubicin liposomal (Primary)
- Indications Kaposi's sarcoma
- Focus Adverse reactions; Therapeutic Use
- 11 Feb 2013 New trial record